Ledger.Open graph →
SEC Form D · Amendment · filed September 28, 2021

Kalgene Phamaceuticals Inc

Offering
$3.7M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MONTREAL, Quebec, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Benoit V. Cyr · Montreal, Quebec, CanadaDirectorThillainathan V. Yoganathan · Montreal, Quebec, CanadaDirectorNickolay V. Kukekov · Montreal, Quebec, CanadaExecAnthony J. Giovinazzo · Montreal, Quebec, CanadaDirectorMichal V. Prywata · Montreal, Quebec, CanadaDirectorSandra M. Cram · Grand Cayman, Cayman IslandsDirectorJwee Liang Teo · Tortola, British Virgin IslandsDirectorArisaig Partners (Asia) Pte Ltd · Singapore, U0ExecDavid N. Choi · Los Angeles, CADirectorSiu Lam Albert M. Lee · Hong Kong, Hong KongDirectorYunyan Grace Li · Palo Alto, CADirectorMasayuki Tanabe · Tokyo, M0ExecMasahiro Otani · Tokyo, M0DirectorKenji Inoue · Tokyo, M0DirectorSadayo Hirata · Tokyo, M0Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗